In this episode, we delve into the fascinating world of T-cell engineering and its transformative impact on cancer immunotherapy. Our spotlight is on TRACeR-I—a groundbreaking strategy to improve antigen recognition by modifying the T-cell receptor (TCR) signaling pathway. You’ll discover how researchers are refining TCR sensitivity and specificity, what it means for personalized cancer treatment, and how this innovation could overcome current limitations in T-cell therapy. Join us as we decode the science behind enhanced immune recognition and explore the future of adaptive cell therapies.